Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

NCT02254941 · clinicaltrials.gov ↗

UNKNOWN

Status

1104

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colon Cancer

Interventions

DRUG: Chemotherapy
BIOLOGICAL: Chemotherapy plus monoclonal antibody

Sponsor

Grupo Espanol Multidisciplinario del Cancer Digestivo